Home

Industry Leading Shopping Blog, CSHBCK, Launches Official Website and Newsletter

Published 2 years ago via Magic PR

CSHBCK is a website designed to help shoppers earn their cash back from retailers and hundreds of online stores. The company is officially launching its website and including a newsletter that customers can use to stay on top of all the news and promotions for getting their cash back and earning other rewards.

The launch of CSHBCK’s official website comes with added features and more blog posts that show buyers how to get some of their cash back from their online and in-store purchases. Shop-a-holics who love purchasing new clothes, beauty products, accessories, and other kinds of cosmetics will find helpful information to get rewards.

How the CSHBCK Website Works

Customers can get rewards and their cash back from purchases made in a wide range of categories. CSHBCK is designed to ensure that customers are able to get their money’s worth and have the best possible shopping experience.

Customers can earn cash and rewards from the following shopping categories:

  1. Pets
  2. Beauty
  3. Home
  4. Garden
  5. Food
  6. Apps
  7. Clothing
  8. Accessories
  9. Entertainment
  10. Travel

Each category on the website provides detailed blogs with information about the different services and products customers typically purchase. Shoppers who love purchasing their cosmetics from stores like Bath & Body Works or even Ulta can learn about how to get rewards by reading the detailed blogs on the CSHBCK website.

Each blog explains the steps that customers need to take if they want to earn their cash  back along with other useful tips that can make their shopping experience so much more beneficial.

Customers tend to look for cash back offers when they are purchasing clothing items and the CSHBCK website has a wide variety of options for them to choose from. Whether customers are getting accessories, athleisure items, or even baby clothes, each blog post is able to guide shoppers on how to make the most of their shopping experience.

The CSHBCK website can help buyers earn rewards from the following stores:

  1. Athleta
  2. Ann Taylor
  3. ASOS
  4. Claire’s
  5. Baby Gap
  6. American Eagle
  7. Lululemon

The list goes on and buyers have the chance to get some cash back from many of their favorite retailers.

The CSHBCK Newsletter

The newsletter is a great way for frequent shoppers to get informed as soon as CSHBCK publishes new blog posts about different retail stores. Those who want to be on top of the news and want to get the best possible deals will greatly benefit from receiving consistent information from this newsletter.

This makes it easier for customers to always know which stores they can get some of their cash back from so that they can have excellent deals and improve their overall shopping experience.

The CSHBCK Backstory

This website was started by a shopping enthusiast who had a passion for earning rewards and cash back from retail stores. Since 2021, CSHBCK has grown to be one of the best shopping blogs with excellent content designed for shop-a-holics who want to get the best deals.

After publishing several blogs over the years and providing valuable information for shopping enthusiasts, CSHBCK is launching its new website and including a newsletter that will make the user experience even better. You can find the official CSHBCK website here: https://cshbck.com

About CSHBCK

CSHBCK is a website that gives shoppers information about getting the best rewards and earning their cash back from both online and in-person retail stores. Shoppers can learn about how to get their cash back from a variety of categories including clothing, food, travel, pets, beauty, home, accessories, and so much more.

Source: https://thenewsfront.com/industry-leading-shopping-blog-cshbck-launches-official-website-and-newsletter/

About CSHBCK

CSHBCK (pronounced cash-back) started up in early 2021, and within a year was coined one of the best shopping blogs.

Contact CSHBCK




Website: https://cshbck.com


Invivoscribe Announces Registration of the LeukoStrat® CDx FLT3 Mutation Assay in the United Kingdom and Switzerland

Published 2 hours ago via Business Wire

Invivoscribe, a global leader in precision diagnostics, is pleased to announce the successful listings of the LeukoStrat CDx FLT3 Mutation Assay in both the United Kingdom (UK) and Switzerland. The LeukoStrat CDx FLT3 Mutation Assay aids in the accurate detection of FLT3 mutations, empowering clinicians to make informed treatment decisions. This milestone ensures expanded accessibility of critical treatments to patients diagnosed with acute myeloid leukemia (AML).

Regulatory compliance in the UK and Switzerland has been achieved through Invivoscribe’s UK Responsible Person (UKRP) and Swiss Authorized Representative (CH-REP), ensuring full adherence to national regulatory frameworks. Both the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK, and Swissmedic in Switzerland—have officially registered this CDx assay. These agencies are responsible for ensuring product safety, efficacy, and compliance with post-market surveillance requirements.

AML is an aggressive and rapidly progressing hematologic malignancy. Making timely and accurate detection of actionable mutations such as FLT3 is critical and essential for optimizing patient outcomes. The LeukoStrat CDx FLT3 Mutation Assay enables rapid same day results and precise identification of FLT3 mutations, which are associated with poor prognosis and targeted treatment options. By providing standardized, reliable and timely FLT3 mutation testing, the assay plays a critical role in precision medicine, helping guide therapeutic decisions and improving the management of AML worldwide.

This registration reinforces Invivoscribe’s commitment to expanding access to high quality, regulatory compliant companion diagnostics that enable clinicians and patients to benefit from cutting-edge advancements in molecular testing.

For more information about the LeukoStrat CDx FLT3 Mutation Assay and Invivoscribe’s comprehensive portfolio of precision diagnostics, please visit www.invivoscribe.com or contact us at inquiry@invivoscribe.com and follow us on Linked In.

EU Intended Use

The LeukoStrat CDx FLT3 Mutation Assay is a PCR-based in vitro diagnostic test designed to detect internal tandem duplication (ITD) and tyrosine kinase domain (TKD) mutations D835 and I836 in the FLT3 gene in genomic DNA extracted from mononuclear cells obtained from peripheral blood or bone marrow aspirates of patients diagnosed with acute myelogenous leukemia (AML). The LeukoStrat CDx FLT3 Mutation Assay may be used as a companion diagnostic for the following therapeutic:

In regions where XOSPATA® (gilteritinib fumarate) is available, the LeukoStrat CDx FLT3 Mutation Assay is used as an aid in the assessment of patients with AML for whom XOSPATA® (gilteritinib fumarate) treatment is being considered.

In regions where VANFLYTA® (quizartinib hydrochloride) is available, the LeukoStrat CDx FLT3 Mutation Assay is used as an aid in the assessment of patients with FLT3-ITD+ AML for whom VANFLYTA® (quizartinib hydrochloride) treatment is being considered.

The qualitative, non-automated test is for use on the 3500xL or 3500xL Dx Genetic Analyzers.

About Invivoscribe

Invivoscribe is a global, vertically integrated biotechnology company dedicated to Improving Lives with Precision Diagnostics®. For nearly thirty years, Invivoscribe has improved the quality of healthcare worldwide by providing high quality standardized reagents, tests, and bioinformatics tools to advance the field of precision medicine. Invivoscribe has a successful track record of partnerships with pharmaceutical companies interested in clinical trial testing via our global lab network located in the US, Germany, Japan and China, and in developing and commercializing companion diagnostics, with our rigorous expertise in both regulatory and laboratory services. Providing distributable kits, as well as clinical trial services through its globally located clinical lab subsidiaries (LabPMM), Invivoscribe is an ideal partner from diagnostic development, through clinical trials, regulatory submissions, and commercialization.

Contacts